Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

BACKGROUND: Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients still die from progressive disease. Current prognostic models predict the outcome of treatment with imperfect accuracy, and clinically relevant biomarkers have not been established to improve on the Interna...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Steidl, Christian, Lee, Tang, Shah, Sohrab P., Farinha, Pedro, Han, Guangming, Nayar, Tarun, Delaney, Allen, Jones, Steven J., Iqbal, Javeed, Weisenburger, Dennis D., Bast, Martin A., Rosenwald, Andreas, Muller-Hermelink, Hans-Konrad, Rimsza, Lisa M., Campo, Elias, Delabie, Jan, Braziel, Rita M., Cook, James R., Tubbs, Ray R., Jaffe, Elaine S., Lenz, Georg, Connors, Joseph M., Staudt, Louis M., Chan, Wing C., Gascoyne, Randy D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897174/
https://ncbi.nlm.nih.gov/pubmed/20220182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0905680
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi